u/eu_apotheke_a

Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.

ask which facility, then ask for their testing

What pack size is that price for?

Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.

How long was the randomised phase before any extension?

Pointing this one at a pharmacist locally. Eligibility questions have national answers we cannot give.

Same. A press release is a claim about a result; the publication is the result.

Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.

potency testing on the finished preparation is the thing to ask for

This. Compounded preparations carry no equivalence claim, and treating them as generics is a category error people make constantly.

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.